dasiglucagon

FDA Drug Profile — Zegalogue

Drug Details

Generic Name
dasiglucagon
Brand Names
Zegalogue
Application Number
NDA214231
Sponsor
Novo Nordisk
NDC Codes
2
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
DASIGLUCAGON

Indications and Usage

1 INDICATIONS AND USAGE ZEGALOGUE ® is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above. ZEGALOGUE is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above. ( 1 )